Encompass Health Co. Announces Quarterly Dividend of $0.28 (NYSE:EHC)

Encompass Health Co. (NYSE:EHC) declared a quarterly dividend on Tuesday, July 20th, Zacks reports. Shareholders of record on Friday, October 1st will be given a dividend of 0.28 per share on Friday, October 15th. This represents a $1.12 dividend on an annualized basis and a yield of 1.40%. The ex-dividend date is Thursday, September 30th.

Encompass Health has increased its dividend payment by 14.3% over the last three years and has raised its dividend annually for the last 1 consecutive years. Encompass Health has a payout ratio of 27.3% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Encompass Health to earn $4.42 per share next year, which means the company should continue to be able to cover its $1.12 annual dividend with an expected future payout ratio of 25.3%.

Encompass Health stock opened at $79.96 on Wednesday. The stock has a market capitalization of $7.96 billion, a PE ratio of 26.22, a PEG ratio of 1.09 and a beta of 1.13. The company has a debt-to-equity ratio of 1.55, a current ratio of 1.23 and a quick ratio of 1.23. The firm’s fifty day simple moving average is $80.27. Encompass Health has a one year low of $60.44 and a one year high of $89.68.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Tuesday, April 27th. The company reported $1.05 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.80 by $0.25. The business had revenue of $1.23 billion for the quarter, compared to the consensus estimate of $1.23 billion. Encompass Health had a return on equity of 15.89% and a net margin of 6.49%. As a group, research analysts anticipate that Encompass Health will post 4.14 earnings per share for the current fiscal year.

Several analysts have weighed in on EHC shares. Deutsche Bank Aktiengesellschaft upgraded Encompass Health from a “hold” rating to a “buy” rating and boosted their price target for the company from $87.00 to $104.00 in a research note on Friday, July 2nd. Raymond James increased their price target on Encompass Health from $90.00 to $95.00 and gave the company an “outperform” rating in a report on Thursday, April 29th. Finally, Mizuho raised their target price on Encompass Health from $90.00 to $94.00 and gave the stock a “buy” rating in a research note on Thursday, April 29th. One investment analyst has rated the stock with a sell rating and seven have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $94.63.

About Encompass Health

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Recommended Story: What is the CAC 40 Index?

Dividend History for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.